To be prescribed Tirzepatide (Mounjaro®) (from June 25) people must:
· Have a BMI of 40 or more, and
· Have at least four or more of the following health conditions:
· Hypertension
· Dyslipidaemia
· Obstructive sleep apnoea
· Cardiovascular disease
· Type 2 diabetes mellitus
Information for patients on new eligibility criteria for Tirzepatide (Mounjaro®) weight loss injections is available on the NHS England website. NHS England » Medicines for obesity and North East and North Cumbria ICB website Advice and support weight-loss drugs information for patients.
NHS England > Medicines for obesity
Advice and support weight-loss drugs information for patients